Delivery Order V797P5261B-VA25113F2540

The Defense Logistics Agency awarded a $4,759.35 delivery order to AmerisourceBergen Drug Corp for Zortress 1 mg tablets (60 unit-dose tablets) on July 22, 2025, with completion targeted for July 23, 2025. This firm fixed-price delivery order was competitively awarded without any set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. Zortress (everolimus) is an immunosuppressant medication commonly used in transplant patients to prevent organ...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of Tacrolimus 5 mg capsules (immediate release) in quantities of 100, with a ceiling value of $1,381.61 and an ultimate completion date of January 2, 2026. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. Tacrolimus is an...

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,814.04 firm fixed-price contract is for the supply of 100 capsules of 1 mg Tacrolimus, an immunosuppressant medication commonly used in organ transplant patients. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA to...

The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21 (VISN 21), awarded a delivery order to Otsuka America Pharmaceutical Inc. for Jynarque (tolvaptan) on September 26, 2023, with a ceiling value of $12,224.60. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2023, was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and did not utilize a set-aside designation. The product will be delivered to...

On August 3, 2020, the Department of Veterans Affairs, through Veterans Integrated Service Network 12, awarded a delivery order to Otsuka America Pharmaceutical Inc. for the supply of Tolvaptan with a ceiling value of $10,102.19. This firm-fixed price delivery order, with an ultimate completion date of August 10, 2020, was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not utilize a set-aside designation. The place of performance is Pittsburgh,...

The Department of Veterans Affairs Veterans Integrated Service Network 21 awarded a $12,580.72 firm fixed-price delivery order to Otsuka America Pharmaceutical Inc. for Jynarque (tolvaptan) on August 5, 2024, with an ultimate completion date of August 19, 2024. This delivery order was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not utilize a set-aside designation. The place of performance is Potomac, Maryland. Jynarque is a specialty pharmaceutical...

On January 4, 2023, the Department of Veterans Affairs (VA), Veterans Integrated Service Network 5, awarded a delivery order to Otsuka America Pharmaceutical Inc. for Jynarque 90mg-30mg with a ceiling value of $12,195.72. The award was made under a firm fixed-price delivery order contract type with no set-aside designation utilized. Jynarque (tolvaptan) is a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia in veteran populations. The contract...

This delivery order, awarded September 8, 2025, by the Defense Logistics Agency (DLA) Medical Supply Chain to AmerisourceBergen Drug Corp, provides 100 tablets of Envarsus XR 4 mg at a ceiling value of $1,711.95. Envarsus XR is an extended-release formulation of tacrolimus, an immunosuppressant medication commonly used in transplant recipients and patients with autoimmune conditions. The contract utilizes firm fixed pricing and is scheduled for completion by September 29, 2025. This award...

The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21 (VISN 21), awarded a delivery order valued at $37,742.16 to Otsuka America Pharmaceutical Inc. on June 25, 2024, with an ultimate completion date of August 26, 2024. This firm-fixed price delivery order procures Jynarque (tolvaptan), a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia in veteran populations. The award was issued under the Pharmaceuticals and Drugs...

Otsuka America Pharmaceutical Inc. received a $13,168.39 firm fixed-price delivery order from Veterans Integrated Service Network 5 (VISN 5) for Jynarque 90mg-30mg, a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia in veteran populations. The delivery order, awarded on June 6, 2025, with an ultimate completion date of June 11, 2025, represents a continuation of supply under the company's broader Federal Supply Schedule contract for...